Great West Life Assurance Co. Can lessened its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 895,012 shares of the pharmacy operator’s stock after selling 34,157 shares during the period. Great West Life Assurance Co. Can’s holdings in Walgreens Boots Alliance were worth $49,548,000 at the end of the most recent quarter.
Several other large investors have also added to or reduced their stakes in the company. Caisse DE Depot ET Placement DU Quebec lifted its stake in Walgreens Boots Alliance by 11.0% in the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,837,465 shares of the pharmacy operator’s stock valued at $647,154,000 after acquiring an additional 1,169,600 shares in the last quarter. Northern Trust Corp lifted its stake in Walgreens Boots Alliance by 0.7% in the 2nd quarter. Northern Trust Corp now owns 11,647,146 shares of the pharmacy operator’s stock valued at $636,750,000 after acquiring an additional 76,864 shares in the last quarter. Morgan Stanley lifted its stake in Walgreens Boots Alliance by 36.2% in the 2nd quarter. Morgan Stanley now owns 4,913,030 shares of the pharmacy operator’s stock valued at $268,595,000 after acquiring an additional 1,304,949 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Walgreens Boots Alliance by 2.4% in the 2nd quarter. Charles Schwab Investment Management Inc. now owns 3,794,775 shares of the pharmacy operator’s stock valued at $207,461,000 after acquiring an additional 90,568 shares in the last quarter. Finally, Parametric Portfolio Associates LLC lifted its stake in Walgreens Boots Alliance by 23.4% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 2,893,195 shares of the pharmacy operator’s stock valued at $158,171,000 after acquiring an additional 549,575 shares in the last quarter. Institutional investors and hedge funds own 59.76% of the company’s stock.
NASDAQ:WBA opened at $55.80 on Tuesday. The firm has a market capitalization of $49.18 billion, a price-to-earnings ratio of 9.27, a price-to-earnings-growth ratio of 1.39 and a beta of 0.89. Walgreens Boots Alliance Inc has a twelve month low of $49.03 and a twelve month high of $86.31. The stock’s 50 day moving average price is $54.50 and its two-hundred day moving average price is $53.32. The company has a quick ratio of 0.37, a current ratio of 0.76 and a debt-to-equity ratio of 0.49.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Monday, October 28th. The pharmacy operator reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The business had revenue of $33.95 billion for the quarter, compared to analyst estimates of $33.88 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. The firm’s revenue was up 1.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.48 EPS. As a group, analysts anticipate that Walgreens Boots Alliance Inc will post 5.97 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be issued a dividend of $0.458 per share. This represents a $1.83 dividend on an annualized basis and a dividend yield of 3.28%. The ex-dividend date is Friday, November 15th. Walgreens Boots Alliance’s payout ratio is presently 30.40%.
WBA has been the topic of several research reports. JPMorgan Chase & Co. cut Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and cut their target price for the company from $73.00 to $63.00 in a research note on Wednesday, October 23rd. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a research note on Thursday, September 12th. They issued a “sell” rating on the stock. Morgan Stanley cut their target price on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating on the stock in a research note on Friday, August 23rd. Royal Bank of Canada lowered Walgreens Boots Alliance to a “hold” rating and set a $59.00 price target on the stock. in a research report on Friday, September 27th. Finally, BidaskClub raised Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research report on Wednesday, September 11th. Seven investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. Walgreens Boots Alliance currently has an average rating of “Hold” and a consensus target price of $61.65.
In related news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the business’s stock in a transaction that occurred on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total transaction of $10,869,505.04. Following the transaction, the chief accounting officer now directly owns 357,851 shares of the company’s stock, valued at approximately $18,064,318.48. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 15.73% of the stock is currently owned by insiders.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Featured Story: How to track put option volume
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.